Document Preview Unavailable
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)
Sheng, Calvin C; Sahoo, Debasis; Dugar, Siddharth; Prada, Robier Aguillon; Wang, Tom Kai Ming; et al. Clinical Cardiology Vol. 43, Iss. 10, (Oct 2020): 1055-1063.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library